COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases
Latest Information Update: 22 Mar 2023
At a glance
- Drugs Elasomeran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Acronyms COVIAAD
Most Recent Events
- 17 Mar 2023 Status changed from active, no longer recruiting to completed.
- 13 Jun 2021 Planned End Date changed from 15 Mar 2022 to 15 Jun 2022.
- 20 Apr 2021 Status changed from recruiting to active, no longer recruiting.